Prevention and control of COVID-19
Information on how to protect yourself and others from COVID-19, including risk groups, vaccines, contact tracing and non-pharmaceutical interventions.
COVID-19 vaccines are being developed following the same legal requirements for quality, safety and efficacy as for all other vaccines.
Efficacy, effectiveness and safety of vaccines against COVID-19
A living systematic review on the efficacy, effectiveness and safety of COVID-19 vaccines authorised in the EU/EEA
After vaccination, non-pharmaceutical interventions are the most effective public health interventions against COVID-19.
Guidance on quarantine and isolation
This guidance aims to provide options for adapting quarantine and isolation particularly when countries face high or extreme pressure on healthcare systems and other functions in society, including essential services.
High-risk groups for COVID-19 are people aged 60 years and older; those living in long-term care facilities; and people with underlying health conditions.
Patient and case management
ECDC resources on patient and case management for COVID-19: patient and case management, protective equipment, diagnosis, prevention, vaccines.
The Response Measures Database (RMD)
The ECDC-JRC database is an archive of non-pharmaceutical interventions (NPIs), or measures, introduced by 30 countries in the European Union and European Economic Area in response to the coronavirus disease (COVID-19) pandemic. The RMD is reviewed and updated every two weeks.
Social contact patterns in the EU/EEA during the COVID-19 pandemic
This survey (CoMix) was conducted to enhance our understanding of contact mixing during the transition period beyond the acute phase of the COVID-19 pandemic.